{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-031864","form_type":"8-K/A","ticker":"PLSH","cik":"0001552189","company_name":"PANACEA LIFE SCIENCES HOLDINGS, INC.","filed_at":"2021-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:12.998091+00:00","generated_at":"2026-06-28T00:06:13.486179+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Panacea Life Sciences 2020 revenue $9.0M, net loss $5.2M; auditor raises going concern","bullets":["Revenue $9.0M in 2020 vs $2.2M in 2019; net loss $5.2M vs $2.8M.","Cash dropped to $84K from $8.5M year-end 2019; total assets $31.4M, liabilities $24.7M.","Auditor raises going concern due to recurring losses; company needs additional capital.","Related party note payable $15.1M at Dec 2020; $1M additional financing received Nov 2021.","Marketable securities (XXII shares) valued at $2.85M; unrealized gain $1.43M in 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-031864","json":"https://secwatch.observer/filing/0001493152-21-031864.json","markdown":"https://secwatch.observer/filing/0001493152-21-031864.md","text":"https://secwatch.observer/filing/0001493152-21-031864.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1552189/000149315221031864/0001493152-21-031864-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1552189/000149315221031864/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T00:06:13.486179+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}